Literature DB >> 23764871

Importance of Legionella pneumophila in the etiology of severe community-acquired pneumonia in Santiago, Chile.

Francisco Arancibia1, Claudia P Cortes2, Marcelo Valdés3, Javier Cerda4, Antonio Hernández5, Luis Soto6, Antoni Torres7.   

Abstract

BACKGROUND: In US and European literature, Legionella pneumophila is reported as an important etiologic agent of severe community-acquired pneumonia (CAP), but in Chile this information is lacking. The aim of this study was to determine the incidence and identify predictors of severe CAP caused by L pneumophila in Santiago, Chile.
METHODS: A multicenter, prospective clinical study lasting 18 months was conducted; it included all adult patients with severe CAP admitted to the ICUs of four hospitals in Santiago. We excluded patients who were immunocompromised, had been hospitalized in the previous 4 weeks, or presented with another disease during their hospitalization. All data for the diagnosis of severe CAP were registered, and urinary antigens for L pneumophila serogroup 1 were determined.
RESULTS: A total of 104 patients with severe CAP were included (mean ± SD age, 58.3 ± 19.3 years; men, 64.4%; APACHE (Acute Physiology and Chronic Health Evaluation) II score, 16.7 ± 6.3; Sepsis-related Organ Failure Assessment score, 6.1 ± 3.2; Pitt Bacteremia Score, 3.4 ± 2.5; Pao2/Fio2, 170.8 ± 87.1). An etiologic agent was identified in 62 patients (59.6%), with the most frequent being Streptococcus pneumoniae (27 patients [26%]) and L pneumophila (nine patients [8.6%]). Logistic regression analysis showed that a plasma sodium level of ≤ 130 mEq/L was an independent predictor for L pneumophila severe CAP (OR, 11.3; 95% CI, 2.5-50.5; P = .002). Global mortality was 26% and 33% for L pneumophila. The Pitt bacteremia score and pneumonia score index were the best predictors of mortality.
CONCLUSIONS: We found that in Santiago, L pneumophila was second to S pneumoniae as the etiologic agent of severe CAP. Severe hyponatremia at admission appears to be an indicator for L pneumophila etiology in severe CAP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23764871     DOI: 10.1378/chest.13-0162

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  12 in total

1.  Is Legionellosis Present and Important in Colombia? An Analyses of Cases from 2009 to 2013.

Authors:  Andrés Mauricio Patiño-Barbosa; Andrés Felipe Gil-Restrepo; Valentina Restrepo-Montoya; Wilmer E Villamil-Gomez; Jaime A Cardona-Ospina; Alfonso J Rodriguez-Morales
Journal:  Cureus       Date:  2017-03-28

Review 2.  Hyponatremia in Infectious Diseases-A Literature Review.

Authors:  Anna L Królicka; Adrianna Kruczkowska; Magdalena Krajewska; Mariusz A Kusztal
Journal:  Int J Environ Res Public Health       Date:  2020-07-23       Impact factor: 3.390

3.  Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective.

Authors:  Andrea Gramegna; Giovanni Sotgiu; Marta Di Pasquale; Dejan Radovanovic; Silvia Terraneo; Luis F Reyes; Ester Vendrell; Joao Neves; Francesco Menzella; Francesco Blasi; Stefano Aliberti; Marcos I Restrepo
Journal:  BMC Infect Dis       Date:  2018-12-18       Impact factor: 3.090

Review 4.  Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.

Authors:  Bin Cao; Yi Huang; Dan-Yang She; Qi-Jian Cheng; Hong Fan; Xin-Lun Tian; Jin-Fu Xu; Jing Zhang; Yu Chen; Ning Shen; Hui Wang; Mei Jiang; Xiang-Yan Zhang; Yi Shi; Bei He; Li-Xian He; You-Ning Liu; Jie-Ming Qu
Journal:  Clin Respir J       Date:  2017-09-26       Impact factor: 2.570

Review 5.  Community-acquired pneumonia.

Authors:  Elena Prina; Otavio T Ranzani; Antoni Torres
Journal:  Lancet       Date:  2015-08-12       Impact factor: 79.321

Review 6.  Diabetes-associated infections: development of antimicrobial resistance and possible treatment strategies.

Authors:  Muhammad Sajid Hamid Akash; Kanwal Rehman; Fareeha Fiayyaz; Shakila Sabir; Mohsin Khurshid
Journal:  Arch Microbiol       Date:  2020-02-03       Impact factor: 2.667

Review 7.  Advances in the prevention, management, and treatment of community-acquired pneumonia.

Authors:  Mathias W Pletz; Gernot G Rohde; Tobias Welte; Martin Kolditz; Sebastian Ott
Journal:  F1000Res       Date:  2016-03-08

8.  Characterization of the nasopharyngeal viral microbiome from children with community-acquired pneumonia but negative for Luminex xTAG respiratory viral panel assay detection.

Authors:  Lili Xu; Yun Zhu; Lili Ren; Baoping Xu; Chunyan Liu; Zhengde Xie; Kunling Shen
Journal:  J Med Virol       Date:  2017-07-25       Impact factor: 2.327

9.  Lefamulin in Patients with Community-Acquired Bacterial Pneumonia Caused by Atypical Respiratory Pathogens: Pooled Results from Two Phase 3 Trials.

Authors:  Susanne Paukner; David Mariano; Anita F Das; Gregory J Moran; Christian Sandrock; Ken B Waites; Thomas M File
Journal:  Antibiotics (Basel)       Date:  2021-12-04

10.  Case report: fatal pneumonia caused by new sequence type Legionella pneumophilia serogroup 1.

Authors:  Luxi Jiang; Sixu Tao; Deguang Mu; Naxin Zhang; Li Zhao; Yu Chen
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.